#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5264	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2245	506.5	0	.	n	.	0	C451T	SNP	451	451	C	830	830	T	641	T,C	417,171	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5264	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2245	506.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1829	1829	T	653	T,C,G	412,182,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5264	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2245	506.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1563	1563	C	628	C,G,T	571,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5264	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2245	506.5	0	HET	.	.	.	C207T,A	.	207	207	C	586	586	C	463	C,T,A	302,106,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9150	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4249	519.1	0	.	n	.	0	T695C	SNP	695	695	T	1372	1372	C	580	C,A	528,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9150	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4249	519.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2648	2648	C	712	C,G,A	654,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9150	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4249	519.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2722	2722	A	685	A	626	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9150	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4249	519.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3274	3274	C	611	C	567	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	714	folP	855	855	100.0	folP.l15.c4.ctg.1	2205	77.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1460	1462	AGC	111;111;109	A;G,T;C	100;100,1;99	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1366	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	84.3	1	SNP	p	S91F	1	.	.	271	273	TTC	872	874	TTC	69;69;69	T;T;C,T	63;63;65,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1366	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	84.3	1	SNP	p	D95G	1	.	.	283	285	GGC	884	886	GGC	74;75;75	G;G;C	70;70;70	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1366	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	84.3	1	SNP	p	G95N	0	.	.	283	285	GGC	884	886	GGC	74;75;75	G;G;C	70;70;70	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1366	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3892	84.3	0	HET	.	.	.	G2377A	.	2377	2377	G	2978	2978	G	87	G,A	62,10	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	430	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1990	52.5	1	SNP	p	G45D	0	.	.	133	135	GGC	742	744	GGC	108;108;106	G;G;C	96;95;96	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	278	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1710	39.0	0	.	n	.	0	A197.	DEL	197	197	A	921	921	A	99	A	91	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3353	140.8	1	SNP	p	D86N	0	.	.	256	258	GAC	756	758	GAC	112;111;113	G,A,T;A,C;C,T	83,1,1;71,1;84,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3353	140.8	1	SNP	p	S87R	1	.	.	259	261	CGT	759	761	CGT	114;116;117	C,T;G;T	97,1;85;86	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3353	140.8	1	SNP	p	R87W	0	.	.	259	261	CGT	759	761	CGT	114;116;117	C,T;G;T	97,1;85;86	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3353	140.8	1	SNP	p	R87I	0	.	.	259	261	CGT	759	761	CGT	114;116;117	C,T;G;T	97,1;85;86	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3353	140.8	1	SNP	p	S88P	0	.	.	262	264	TCC	762	764	TCC	117;118;118	T;C,T;C,T	98;98,1;103,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1438	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3575	97.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2057	2059	GGC	97;99;99	G;G;C	85;85;78	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1382	1384	GCC	137;140;140	G;C;C,A,G	128;130;128,1,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1385	1387	ATG	139;136;135	A;T,A,G;G	129;123,2,1;125	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1397	1399	ACC	139;139;139	A,T,C;C;C,A	125,2,1;130;129,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1397	1399	ACC	139;139;139	A,T,C;C;C,A	125,2,1;130;129,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1898	1900	ACC	126;125;124	A;C,A;C	110;106,1;109	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1952	1954	GCG	118;118;117	G;C;G	103;95;98	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1952	1954	GCG	118;118;117	G;C;G	103;95;98	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2075	2077	GGT	108;108;109	G;G,T;T,G	99;95,3;97,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2084	2086	AGC	100;99;98	A,G;G;C,G	66,1;77;67,4	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1198	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2382	116.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2102	2104	CCG	86;86;85	C,G;C;G,C	64,2;67;66,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1648	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3904	101.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2063	2065	CCG	139;139;139	C,G,T;C,G;G,C	100,4,2;120,2;91,12	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	710	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2604	66.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	928	928	C	55	C	45	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	272	90.58	porB1a.l15.c17.ctg.1	991	14.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	744	746	AAT	14;14;13	A;A;T	12;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	272	90.58	porB1a.l15.c17.ctg.1	991	14.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	747	749	AAT	13;13;9	A,C;A;T	12,1;13;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	272	90.58	porB1a.l15.c17.ctg.1	991	14.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	771	773	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	272	90.58	porB1a.l15.c17.ctg.1	991	14.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	794	796	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	272	90.58	porB1a.l15.c17.ctg.1	991	14.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	803	803	A	4	A	4	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	910	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2515	86.3	1	SNP	p	G120K	1	.	.	358	360	AAG	1075	1077	AAG	104;104;103	A,C;A;G,A	91,5;98;95,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	910	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2515	86.3	1	SNP	p	A121N	1	.	.	361	363	AAC	1078	1080	AAC	106;106;106	A;A;C	99;101;99	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	910	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2515	86.3	1	SNP	p	N121D	0	.	.	361	363	AAC	1078	1080	AAC	106;106;106	A;A;C	99;101;99	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3362	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5529	146.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	374	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1785	51.3	1	SNP	p	V57M	1	.	.	169	171	ATG	846	848	ATG	118;117;117	A;T;G	106;108;108	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
